Placental Stem Cell Therapy for Neurological Disorders Market Report on the Untapped Growth Opportunities in the Industry

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Placental Stem Cell Therapy for Neurological Disorders Market- (By Type (Allogeneic Placental Stem Cell Therapy, Autologous Placental Stem Cell Therapy), By End-User (Hospitals & Specialty Clinics, Clinics Research Organizations, Research Institutes & Academics)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Placental Stem Cell Therapy for Neurological Disorders Market is valued at US$ 384.09 Mn in 2022, and it is expected to reach US$ 2,049.44 Mn by 2031, with a CAGR of 20.6% during a forecast period of 2023-2031.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2121

The placenta plays a vital role in supporting the exchange of gases, nutrients, and waste removal during pregnancy, which is crucial for fetal development. In recent years, the increasing utilization of human amniotic/amnion epithelial cells (hAECs) in regenerative medicine has significantly boosted investments in the placental stem cell therapy market for neurological disorders. Allogeneic hAECs have shown promising results in clinical trials for conditions such as leukemia and bronchopulmonary dysplasia (BPD), driving market growth, especially in developed regions where the adoption of allogeneic stem cell transplantation procedures is expanding.

The high cell yield of the placenta, coupled with its minimal exposure to infections due to its sterile environment, reduces the risk of disease transmission, positioning it as a key factor driving the growth of the placental stem cell therapy market for neurological disorders.

List of Prominent Players in the Placental Stem Cell Therapy for Neurological Disorders Market:
• Mesoblast Ltd.
• Pleurite Therapeutic
• Remeron Group
• AthersysInc
• Cordlife India
• Life Cell International Pvt. Ltd
• Cryo-Cell International Inc.
• CBR Systems
• Cellularity Inc.
• Cynara
• Others

Market Dynamics:
Drivers-
The regenerative medical approach, which focuses on repairing damaged cells, has proven to be an effective solution for various medical conditions. Numerous companies are conducting foundational research and preclinical studies to explore the potential of stem cells in tissue regeneration for treating neurological disorders. Notably, significant investments in cellular therapies, particularly for cancer treatment, are expected to further propel market growth.

Curious about this latest version of the report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2121

Challenges:
The lack of standardized protocols, comprehensive understanding, and clear guidelines for placental stem cell therapy procedures can lead to variability in treatment outcomes and hinder broader market adoption. Additionally, insufficient awareness among healthcare providers and patients about the potential benefits and availability of placental stem cell therapies may limit market growth.

Regional Trends:
The North American market for placental stem cell therapy for neurological disorders is expected to capture a significant market share. This growth is primarily driven by the presence of key industry players and their strategic initiatives. The Asia-Pacific region holds the second-largest share in the global market, with its robust healthcare infrastructure playing a key role in influencing the expansion of the placental stem cell therapy market for neurological disorders.

Recent Developments
• In Jan 2021, Celularity Inc. made an announcement regarding the release of the 100th cord blood stem cell unit by its Lifebank subsidiary. This unit will be utilised in an autologous cord blood transplant procedure, specifically aimed at treating an eight-year-old youngster who has been diagnosed with autism spectrum disorder.

Curious about this latest version of the report? @
https://www.insightaceanalytic.com/customisation/2121

Segmentation of Placental Stem Cell Therapy for Neurological Disorders Market-
By Type
• Allogeneic Placental Stem Cell Therapy
• Autologous Placental Stem Cell Therapy
By End-User
• Hospitals & Specialty Clinics
• Clinics Research Organizations
• Research Institutes & Academics
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get more information : @
https://www.insightaceanalytic.com/report/placental-stem-cell-therapy-for-neurological-disorders-market/2121

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.